NCT04389645View on ClinicalTrials.gov

Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

April 7, 2020

Primary Completion Date

May 12, 2020

Study Completion Date

May 12, 2020

Conditions
COVID-19
Interventions
DIAGNOSTIC_TEST

IP-10 in CDS protocol

Dynamic IP-10 measurements in hospitalized COVID-19 positive patients

Trial Locations (1)

Unknown

Rabin Medical Center, Petah Tikva

Sponsors
All Listed Sponsors
lead

MeMed Diagnostics Ltd.

INDUSTRY

NCT04389645 - Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients | Biotech Hunter | Biotech Hunter